HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vescovini, R. Articles by Sansoni, P. Search for Related Content PubMed PubMed Citation Articles by Vescovini, R. Articles by Sansoni, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Massive Load of Functional Effector CD4⁺ and CD8⁺ T Cells against Cytomegalovirus in Very Old Subjects¹

Rosanna Vescovini^*, Claudia Biasini^*, Francesco F. Fagnoni, Anna Rita Telera^*, Luca Zanlari^*, Mario Pedrazzoni^*, Laura Bucci, Daniela Monti, Maria Cristina Medici, Carlo Chezzi, Claudio Franceschi^¶ and Paolo Sansoni^2,*

^* Department of Internal Medicine and Biomedical Sciences, University of Parma, Parma, Italy; Laboratory of Experimental Oncology, Scientific Institute of Pavia Fondazione S. Maugeri Clinica del Lavoro e della Riabilitazione, Istituto di Ricovero e Cura a Carattere Scientifico, Pavia, Italy; Department of Experimental Pathology and Oncology, University of Florence, Florence, Italy; Section of Microbiology, Department of Pathology and Laboratory Medicine, University of Parma, Parma, Italy; ^¶ Department of Experimental Pathology, University of Bologna and Interdepartmental Centre for Studies on Biophysics, Bioinformatics and Biocomplexity L. Galvani, Bologna, Italy

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
A progressive, systemic, and low-grade proinflammatory status is one of the major characteristics of immunosenescence. Emerging data suggest a possible contribution of CMV, known to chronically infect a large proportion of humans, lifelong from newborns to centenarians. To test this hypothesis, we evaluated functional T cell responses to two CMV immunogenic proteins, pp65 and IE-1, in 65 chronically infected subjects aged 25–100 years. PBMC were stimulated with mixtures of peptides spanning the entire sequence of both proteins, and Ag specificity and magnitude of intracellular IFN-- and TNF--positive cells were then analyzed within both CD4⁺ and CD8⁺ T cells. Results indicate that pp65 and, to a lesser extent, IE-1 constitute major Ags against which aged people target functionally efficient T cell effector responses with massive production of Th1 cytokines and exhibition of CD107a degranulation marker. As a result, the production of IFN- induced in T cells by both Ags was seven to eight times greater in very old than in young subjects. The comparative analysis of pp65-specific responses in these very long-term carriers revealed a reciprocal relationship between CD4⁺ and CD8⁺ producing IFN- in the same individuals. These results indicate that CMV represents an important pathogen responsible for a strong immune activation in human aging. Such a remarkable burden of effector CD4⁺ and CD8⁺ T cells may be necessary to protect the elderly from CMV endogenous reactivation, but can turn detrimental by giving a substantial contribution to the proinflammatory status that accompanies the main age-related diseases.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Inflammatory mechanisms play a prominent role in the pathogenesis of many age-related diseases and possibly in the primary process of aging itself. Some evidence—including a decrease in naive T cell, accumulation of memory T cells, loss of CD28 costimulatory signal, increased number of CD8⁺ T cells producing IFN-, and increased levels of proinflammatory cytokines—indicate that a peculiar activation of the immune system accompanies the aging process in humans (1, 2, 3, 4, 5, 6). However, the basic mechanisms underlying this chronic inflammatory status in aged humans, we proposed to call inflamm-aging (7), are still elusive.

The -herpesvirus CMV is a common pathogen that infects more than half of the adult population. After primary infection, generally silent in immunocompetent hosts, it establishes a persistent chronic infection controlled by constant immune surveillance. The most important defense against CMV is provided by T cells, as indicated by the observation that uncontrolled viral replication and end-organ diseases occur in individuals with severely impaired T cell functions, including transplant recipients, late stage-HIV patients, and congenitally infected neonates. A remarkable study (8) demonstrated that healthy seropositive subjects aged 19–55 years maintain CMV under control by broadly targeting the overall CMV proteome with 4–5% of both CD4⁺ and CD8⁺ peripheral T cell producing intracellular IFN-. Such a surprisingly high burden of T cells producing IFN- in adulthood raises the possibility that the impact of CMV infection on effector T cells in aged subjects might be even greater, considering the persistence of the CMV infection over decades and the variety of molecular and cellular alterations occurring in immunosenescence.

In recent years, it has become evident that CMV chronic infection contributes to a number of modifications that characterize immunosenescence (9, 10). Several studies on CD8⁺ T lymphocytes with HLA class I tetramers reported that elderly subjects exhibit an increase in T cells specific for CMV-derived epitopes, constituting oligoclonal T cell expansions, with phenotype of highly differentiated effector cells (11, 12, 13, 14). Functional analysis of these CMV-specific CD8⁺ T lymphocytes has shown that, after epitope-specific stimulation, old subjects have a lower proportion of IFN--producing T cells than younger donors, thus suggesting accumulation of dysfunctional CD8⁺ T lymphocytes (12, 14, 15) and that aging and CMV lead to the Th1-oriented cytokine production profile of CD8⁺ T cells (16). As regards CD4⁺ T cells and CMV infection, few studies are available (17, 18). In particular, Fletcher et al. (17) showed that old carriers have higher percentages of CD4⁺ T cells producing IFN- in response to CMV lysate and bearing a late differentiated phenotype with very short telomeres. Apart from possible discrepancies among different studies, the emerging main concept from these results is that anti-CMV T cells in elderly have restricted clonality, terminally differentiated phenotype, and some dysfunctional aspects. However, several questions remain unanswered, including the contribution of anti-CMV responses to inflamm-aging and the Ags possibly selected after long-lasting infection, among others.

This study focused on the simultaneous evaluation of functional age-related CMV-specific CD8⁺ and CD4⁺ responses to two immunogenic CMV proteins: the major immediate early 1 gene product (IE-1)³ and the structural phosphoprotein pp65. To this end, we stimulated freshly drawn PBMC from subjects of different ages (age range: 25–100 years, subdivided into three groups aged 25–40, 65–85, and >85 years old) with mixtures of peptides spanning the entire sequence of both proteins and analyzed Ag specificity and magnitude of intracellular IFN-- and TNF--positive cells within both CD4⁺ and CD8⁺ T cells.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Subjects

We studied 65 CMV-seropositive subjects of three different age groups: young: 14 subjects 25–40 years old (mean age = 29 ± 3.9); old: 25 subjects 65–85 years old (mean age = 74 ± 6.6); oldest old: 26 subjects >85 years old (mean age 90.6 ± 4). Young donors were recruited from healthy staff members. Elderly were recruited randomly from the general public or institutions and all met the following exclusion criteria: absence of diabetes, cancer, severe renal failure, severe liver disease, endocrine disorders, autoimmune diseases, or acute infectious disease; they were not consuming drugs whose activity is known to modify the functions of the immune system. The study was performed after approval from the Ethics Committee of the University of Parma.

CMV serology

Indirect chemiluminescence immunoassays (Liaison CMV IgG and IgM assays; DiaSorin) were used for the quantitative determination of serum-specific IgG and IgM Abs to human CMV. Samples were analyzed by a photomultiplier Liaison. All donors recruited were IgG positive and IgM negative.

Stimulation with PepMix, intracellular staining, and detection of CD107a expression

PBMC were obtained by Ficoll density gradient centrifugation (Biocoll separating solution; Biochrom) from freshly drawn venous blood. After washing with PBS, PBMC were resuspended in RPMI 1640 medium supplemented with 10% FCS, 2 mM/L L-glutamine, 100 µg/ml streptomycin, and 100 U/ml penicillin (complete medium). In all experiments, the cells were immediately stimulated with PepMixes (JPT Peptide Technologies). The PepMix pp65 contains 138 peptides (15-aa peptides with an overlap of 11 aa) spanning the 65-kDa lower matrix phosphoprotein. The PepMix IE-1 contains 120 peptides spanning the 55-kDa immediate-early protein 1. More detailed information on these products can be found at www.jpt.com/products/peptides/pepmix.htm. All of the peptides from a given CMV protein were used in a single tube for stimulation purposes. In each tube, we used 10 µl of complete medium containing a 1 µg/ml final concentration of each peptide spanning the pp65 or IE-1 CMV protein. Intracellular cytokine detection was performed in accordance with the protocol recommended by JPT Peptide Technologies and was well-described (19), together with the measurement of CD107a Ag exposure (20). Briefly, 10⁶ PBMC were placed in 15-ml conical polypropylene tubes (Corning) in a final volume of 500 µl of complete medium and incubated with: 10 µl of complete medium containing one test volume of each PepMix, 1 µg each of the costimulatory mAbs CD28 and CD49d (BD Immunocytometry Systems) and a saturating amount of PE-Cy5-conjugated anti-CD107a mAb (BD Biosciences/BD Pharmingen). In every experiment, negative controls (incubation with anti-CD28/CD49d but not with PepMixes) were included to detect spontaneous production of cytokine and expression of CD107a. The tubes were placed in a standard incubator (37°C, humidified CO₂ atmosphere) and, after 1 h, each tube received the addition of 500 µl of complete medium containing the protein transport inhibitor monensin (Golgi Stop; BD Biosciences/BD Pharmingen). After an additional 4 h, PBMC were washed once with ice-cold PBS and fixed by incubation for 10 min at room temperature with 1 ml of FACS lysing solution (BD Biosciences). After fixing, the cells were washed twice with wash buffer (PBS containing 0.5% BSA (Sigma-Aldrich) and 0.1% sodium azide (NaN₃; Sigma-Aldrich)) and placed at 4°C overnight. The next day, the samples were permeabilized by incubation for 10 min at room temperature with 500 µl of FACS Permeabilizing Solution 2 (BD Biosciences). Cells were washed twice with wash buffer and then stained with saturating amounts of the following Abs: FITC-conjugated IgG1 isotype control Ig or anti-IFN- or anti-TNF-, PE-conjugated anti-CD4, and allophycocyanin-conjugated anti-CD8 (all from BD Biosciences/BD Pharmingen). After 30 min of incubation at room temperature in the dark, the samples were washed once with wash buffer and analyzed.

Flow cytometry and data analysis

Six-parameter flow cytometric analysis was performed on a two-laser FACSCalibur instrument (BD Biosciences) using CellQuest software (BD Biosciences). For each sample, data from almost 0.5 x 10⁶ total events were collected. Files were gated on small lymphocytes (using forward vs side scatter) and cytokine-secreting populations were defined as the percentage of the IFN--positive or TNF--positive events gated on CD4⁺ and on CD8⁺ bright T cell population minus the percentage of the events falling into the same region in the corresponding control sample. The smallest responses classified as positive encompassed 0.03% of the respective reference T cell population. Smaller net responses, after subtraction of percentage of the events in the corresponding control sample, could not be discriminated from "background noise" and were rated as negative. CD107a vs cytokine plots were analyzed to evaluate the exposure of CD107a degranulation marker on anti-pp65 and anti-IE-1 CD4⁺ or CD8⁺ cytokine-secreting T cells, after specific stimulation. The setting for CD107a staining was defined on the basis of an isotype-matched negative control of irrelevant specificity in separate unstimulated culture. To obtain the absolute numbers of cytokine-secreting T cells, we used total lymphocyte counts from quality certified clinical laboratory analysis and additional flow cytometric quantification of CD4⁺ and CD8⁺ T cell frequencies. The absolute numbers of anti-pp65 and anti-IE-1 IFN-- or TNF--producing CD4⁺ and CD8⁺ T cells per milliliter of peripheral blood were calculated multiplying lymphocyte counts by the frequency of CD4⁺ and CD8⁺ T cells in the lymphocyte gate by the frequency of cytokine-secreting cells within total CD4⁺ and CD8⁺.

Statistical analysis

The Kruskal-Wallis nonparametric test was used to derive p values for comparing data among all three donor groups, whereas the Mann-Whitney U nonparametric test was used for comparing data between groups. The nonparametric Spearman rank correlation coefficient test was used to determine the correlation between anti-pp65 CD4⁺ vs CD8⁺ T cell responses. Statistical tests were performed with Statview software; p values <0.05 were considered significant.

	Results

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Functional T cell responses mediated by IFN- and TNF- against pp65 and IE-1 proteins

A comparison among the three age groups confirmed that the frequency of subjects showing CD8⁺ T cell responses to pp65 and IE-1 proteins in people older than 65 years was about two and three times as much as that observed in young adults, respectively, but the number of responders did not increase further in the group of oldest old (Table I). A similar age-related pattern was observed when considering the intensity of CD8⁺ T cell response. The production of IFN- and TNF- (Fig. 1) after stimulation with either pp65-derived or IE-1 peptides were increased in both groups of old subjects when compared with young adults. Representative plots of anti-pp65 and anti-IE-1 CD8⁺ responses mediated by IFN- of donors of different age are shown in Fig. 1A. Overall, functional CD8⁺ T cell responses against CMV in the three age groups revealed a significant increase in responder frequency as well as percentage (Fig. 1, B and C for IFN-, F and G for TNF-), and absolute numbers of cells (Fig. 1, D and E for IFN-, H and I for TNF-) from young to old subjects, whereas anti-CMV CD8⁺ T cells secreting IFN- and TNF- were not increased in the oldest old when compared with old subjects. As regards CD4⁺ T cells, representative plots of anti-pp65 and anti-IE-1 CD4⁺ responses mediated by IFN- of donors of different age are shown in Fig. 2A. The pattern of CD4⁺ T cell responses to the same CMV Ags showed some distinctive aspects when compared with CD8⁺ T cell responses: 1) the frequency of subjects showing CD4⁺ T cell responses to pp65 was similar in the group of young and old subjects but increased in the oldest old (Table I); 2) both the percentage and absolute number of IFN--producing CD4⁺ T cells in response to pp65 showed a significant increase only in the group of the oldest old, (Fig. 2, B and D); 3) both the percentage and absolute number of TNF--producing CD4⁺ T cells in response to pp65 tended to increase in both groups of old subjects, but this did not reach statistical significance; 4) we found uniformly low anti-IE-1 CD4⁺ T cell responses at all ages without any significant difference among the three groups for both cytokines (Fig. 2, C and E for IFN-, H and I for TNF-). Nevertheless, CD4⁺ responses to IE-1 were present because a small but significant percentage of subjects had cell counts above the threshold of the detection method (Table I and Fig. 2, C and E). Thus, the results obtained by the analysis of distinct Ag-specific response indicated that, despite the reported broad Ag targeting, a significant amount of functional CD4⁺ T cell responses were directed against pp65, whereas the contribution of IE-1 to age-related accumulation of effector T cells appeared to be negligible. Finally, a comprehensive assessment of CD3⁺ T cell responses against both pp65 and IE-1 can be envisaged, to quantify the overall weight of functional cytokine-producing T cell in the peripheral blood of donors of different age. As shown in Fig. 3, a significant difference among the three age groups was found. In particular, the medians of percentage of IFN--producing CD3⁺ T cells increased 3- and 8-fold in old and in very old subjects, respectively, in comparison with young adults (Fig. 3A), and this increment is also paralleled by the absolute number of circulating T cells (Fig. 3B). In all three age groups, percentages and absolute numbers of TNF--producing CD3⁺ T cells were considerably lower than IFN--positive CD3⁺ T cells, but a significant increase (Fig. 3, C and D) was found in old and very old subjects in comparison with young adults. These data indicate that aged people are exposed to a heavy loading of effector T cells functionally competent for the production of proinflammatory cytokines in response to CMV proteins.

View larger version (32K): [in this window] [in a new window]   FIGURE 1. Age-related functional CD8+ T cells responses to pp65 and IE-1 CMV– proteins. A, Representative flow cytometry plots of anti-pp65 and anti-IE-1 CD8+ responses of donors of different age. PMBC were unstimulated (negative control) or stimulated with mixtures of peptides spanning the entire sequence of pp65 and IE-1 CMV proteins. Following in vitro Ag-specific stimulation, PBMC were stained as described in Materials and Methods. The cluster of events gated corresponds to the responder CD8+ T cells for each protein. The data are expressed as percentage of cells expressing intracellular IFN- within CD8+ bright T cell subset. The individual data of all donors of different age groups are also shown, both as percentage (B and C) and as absolute number (D and E) of circulating pp65- (green symbols) and IE-1- (magenta symbols) specific IFN--producing CD8+ T cells and both as percentage (F and H) and as absolute number (G and I) of circulating pp65- and IE-1-specific TNF--producing CD8+ T cells. Bars indicate means. Values of p for comparing data between different donors groups are calculated by the Mann-Whitney U nonparametric test.

View larger version (30K): [in this window] [in a new window]   FIGURE 2. Age-related functional CD4+ T cells responses to pp65 and IE-1 CMV– proteins. A, Representative flow cytometry plots of anti-pp65 and anti-IE-1 CD4+ responses of donors of different age. PMBC were unstimulated (negative control) or stimulated for 5 h with mixtures of peptides spanning the entire sequence of pp65 and IE-1 CMV proteins. Following in vitro Ag-specific stimulation, PBMC were stained as described in Materials and Methods. The cluster of events gated corresponds to the responder CD4+ T cells for each protein. The data are expressed as percentage of cells expressing the intracellular IFN- within CD4+ T cell subset. The individual data of all donors of different age groups are also show, both as percentage (B and C) and as absolute number (D and E) of circulating pp65- (green symbols) and IE-1- (magenta symbols) specific IFN--producing CD4+ T cells and both as percentage (F and H) and as absolute number (G and I) of circulating pp65- and IE-1-specific TNF--producing CD4+ T cells. Bars indicate means. Values of p for comparing data between different donors groups are calculated by the Mann-Whitney U nonparametric test.

View larger version (23K): [in this window] [in a new window]   FIGURE 3. Age-related functional CMV-specific T cells responses. Box plots show the range, median, 25th and 75th percentiles of percentages (A and C) and absolute numbers (B and D) of IFN-- and TNF--producing T cells in different age groups. Values of p for comparing data between different donors groups are calculated by the Mann-Whitney U nonparametric test.

To get further insights into the functional profile of anti-CMV T cells, we measured the cell surface exposure of CD107a, a glycoprotein (LAMP-1) associated with the membrane of cytotoxic granules, as a reliable marker of fresh degranulation and cytotoxic potential (20, 21). Representative plots of CD107a expression, after stimulation with CMV proteins, on CD8⁺ and CD4⁺ T cell response of donors of different age, are shown in Fig. 4A. The proportion of cells expressing CD107a on CD4⁺ and CD8⁺ T cells producing IFN- in response to either pp65 or IE-1, within each group of subjects, is plotted in Fig. 4B. The fraction of CD8-mediated responses bearing a marker of cytotoxic capacity was higher in both elderly groups in comparison to young subjects. In particular, CD107a-positive cells reached approximately two-thirds and one-third of the CD8⁺ T cells producing IFN- against pp65 and IE-1, respectively. In contrast, the proportion of CD4⁺ T cells producing IFN- with coexpression of CD107a was significantly lower than that exhibited by CD8⁺ T cells for pp65 and was negligible for IE-1 (Fig. 4B). It is interesting to note that, despite the wide individual variability, the group of oldest subjects had approximately one-third of CD4⁺ T cells responding to pp65 that coexpressed CD107a, a proportion significantly higher than that found in the other two groups.

View larger version (34K): [in this window] [in a new window]   FIGURE 4. Exposure of CD107a degranulation marker on anti-pp65 and anti-IE-1 CD8+ and CD4+ T cell responses in donors of different age. A, Representative flow cytometry plots of CD107a expression, after stimulation with pp65 and IE-1 CMV-proteins, on CD8+ and CD4+ T cells of donors of different age. In each plot, numbers indicate percentages of anti-pp65 and anti-IE-1 IFN- producing T cells positive (upper right quadrant) or negative (lower right quadrant) for the CD107a degranulation marker within the CD8+ or CD4+ subset. B, The individual data of all donors of different age groups are shown as proportion of cells expressing CD107a on IFN--producing CD4+ and CD8+ T cells in response to either pp65 or IE-1. Bars indicate median; statistical analysis of data between different donors groups is calculated by the Mann-Whitney U nonparametric test (*1: >85 vs 25–40, p = 0.02; *2: 65–85 vs 25–40, p = 0.02; *3: >85 vs 25–40, p = 0.02; *4: 65–80 vs 25–40, p = 0.03).

The difference in the magnitude of the CD8 and CD4 responses to IE-1 and the prevalence of responses to pp65 prompted us to verify the relationship between CD8 and CD4 T cell responses to this latter Ag. On the whole, the data regarding IFN--producing T cells indicate that within the group of oldest subjects, both the percentage of responder CD4⁺ and CD8⁺ T cells (80.68% for CD8⁺ vs 84.6% for CD4⁺, Table I), as well as the magnitude of the response to pp65 are comparable (1633 cells/ml median for CD8⁺ T cells vs 2647 cells/ml median for CD4⁺ T cells, Fig. 5A). However, when comparison was made on an individual basis, in all subjects tested, a trend for a disproportion between specific CD4⁺ and CD8⁺ T cells response was observed. Indeed, subjects with high CD4⁺ T cell response exhibited low CD8⁺ T cells response and vice versa (Fig. 5B) and the statistical analysis by the nonparametric Spearman rank correlation coefficient test was found to be significant (p = 0.022).

View larger version (14K): [in this window] [in a new window]   FIGURE 5. Relationship between anti-pp65 CD4+ and CD8+ T cells responses. A, Box plots show the magnitude (range, median, 25th and 75th percentiles) of anti-pp65 CD4+ and CD8+ T cells responses (number of circulating IFN--positive T cells/ml of peripheral blood) in the oldest subjects group. B, Correlation between anti-pp65 CD4+ vs CD8+ T cells responses in all donors tested. Data are represented as dots corresponding to numbers of anti-pp65 IFN--positive CD4+ and CD8+ T cells per milliliter of peripheral blood of each donor. (rs) and p are calculated by nonparametric Spearman rank correlation coefficient test.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

A major aim of the present study was to explore the so far neglected CMV-specific CD4⁺ T cell responses in elderly people. Our results confirmed that anti-CMV CD4⁺ T cells accumulate in very long-term carriers, as reported (17, 18), but also added new information on the fine Ag specificity underlying the age-related remodeling of T cell repertoire. Indeed, CD4⁺ T cells showed, in comparison to CD8⁺ T cells, a preferential response to pp65 Ag and only a negligible one to IE-1 Ag. The importance of pp65 protein as target for the CD4⁺ T cell subset in CMV-exposed individuals is well-known (26, 27, 28, 29). Our data further underline the dominance of pp65 in the elderly as demonstrated by intracellular cytokine production and potential cytotoxic activity. Circulating CD4⁺ T cells ready to mediate direct killing of infected HLA class II-expressing cells have been described in several chronic infections including CMV (30, 31, 32, 33, 34, 35). Concerning the Ag specificity of anti-CMV CD4⁺ CTLs, CMV glycoprotein B recognition has been formally proved in vitro (33) and a recent study demonstrated ex vivo (36) that highly differentiated CD4⁺ T cells, specific for CMV pp65, mediate antiviral effector functions. Our observation that in very old donors about one-third of CD4⁺ T cells reacting to pp65 expressed a marker of fresh degranulation activity (Fig. 4) confirms that this Ag is relevant to induce the direct attack of CD4⁺ T cells on CMV-infected cells. We can envisage that such targets may include cells expressing HLA class II after activation by local release of IFN- and TNF-, such as endothelial, epithelial, and glial cells. Assuming that these cytotoxic CD4⁺ T cells might have a critical role in the control of CMV infection and/or reactivation, the use of pp65 for immunization purposes should be targeted to stimulate both helper and cytolytic CD4⁺ T cells.

Besides the CD4⁺ T cell, effector CD8⁺ T cell responses to pp65 and IE-1 were also found to be expanded in our aged subjects, both in terms of cytokine production and cytotoxic potential. Such proteins are indeed widely recognized by the CD8⁺ T cell subset in seropositive subjects at any age (37, 38, 39, 40). The higher exhibition of CD107a on pp65- vs IE-1-specific CD8⁺ T cells (Fig. 4B) extends to long-term carriers the greater cytotoxic potential of pp65 over IE-1-specific CD8⁺ T cell, described in various clinical settings (41, 42). As regards CD8⁺ T cells, the main finding of our study is that we observed an age-related expansion of functional effector CD8⁺ T cells against pp65 and IE-1, despite the age-related impairment described in the largest CMV-specific CD8⁺ T cell clones (12, 14, 15). The overall picture emerging from previous studies on the response to CMV-specific peptides on HLA class I molecules (12, 14, 15), and the results of the present investigation on the response to peptides spanning entire proteins, is that CMV not only appears to drive differentiation of T cells toward the late effector phase (43), but–we can speculate—it may also induce concurrent quantitative expansion of both functional and dysfunctional elements.

When considering both CD4⁺ and CD8⁺ T cell responses, it appears that the expansion of functional effector T cell responses is a general age-related phenomenon in CMV-seropositive subjects. Nonetheless, the comparative analysis between CD4⁺ and CD8⁺ T cells revealed some intriguing aspects. First, the CD8⁺ response to IE-1 was not necessarily paralleled by CD4⁺ T cell responses with the same Ag specificity. Second, when comparing CD4⁺ and CD8⁺ T cells against pp65 in old donors showing the strongest responses, only a few subjects showed quantitatively similar CD4⁺ and CD8⁺ responses. In many other subjects, a disproportion between the CD4⁺ and CD8⁺ response was found, characterized by an inverse correlation between anti-pp65 IFN--positive CD4⁺ and CD8⁺ T cells (Fig. 5). In any case, the interplay between CD4⁺ and CD8⁺ T cells in CMV infection deserves further studies, with particular attention to the role of CD4⁺ T cells for the maintenance of the CTL effector anti-CMV response (44) and to the biological significance of the inverse relationship between the CD4⁺ and CD8⁺ responses.

The main observation from our study consisted of a several-fold age-related expansion of functional effector T cells after stimulation with only two immunogenic proteins of CMV. The frequency of responders to these proteins was high (Table I), but this analysis cannot be considered by any mean representative of the overall T cell response to CMV which, in contrast, is targeted against many other Ags (8). Assuming that broad targeting of numerous CMV Ags may be conserved throughout aging, and that expansions similar to the one reported here may also occur for other numerous CMV Ags, it can be estimated that the frequency of 4–5% of IFN--producing T cells seen in adulthood may well rise to 20–50% in very old people. If this holds true, CMV would represent by far the most important agent of effector T cell expansion and probably one of the most important causes for persistent immune activation in human aging. Such an enormous and stable burden of effector CD8⁺ and CD4⁺ T cells producing IFN-, most of which is also producing TNF- and showing potential cytotoxic activity, may be necessary to protect the elderly from CMV endogenous reactivation, but may also be detrimental at the systemic and/or tissue level. Consistent with this hypothesis, longitudinal studies tracking an immune risk phenotype in the elderly have already reported a cluster of immune parameters predictive for mortality including CMV seropositivity along with elevated serum levels of proinflammatory cytokines, and other parameters related to effector T cell expansion (45, 46, 47, 48). These findings have been recently strengthened by the observation that CMV is one of the driving forces for acquiring immune risk phenotype (49). The present study adds a new piece to this picture by showing that expansion of functional effector T cell responses is a general age-related phenomenon in CMV-seropositive subjects that, according to the "inflamm-aging" theory, probably plays a relevant role in determining the inflammatory status in human aging.

	Acknowledgments

 
We thank Prof. Edgar G. Engleman for critical review of the manuscript, Drs. G. Benassi, G. Boldrocchi, M. F. Cipani, S. Guerra, and G. Pizzarotti, for their precious help in the recruitment of elderly subjects and Drs. T. Cocchi and P. Avanzini from the Department of Immunehaemathology and Transfusional Center of Parma Hospital.

	Disclosures

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
The authors have no financial conflict of interest.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This work was supported by a grant (to P.S. and D.M.) from Ministero dell’Università e della Ricerca (PRIN2004, ex 40%) "Invecchiamento e Sistema Immunitario nell’uomo: ruolo della stimolazione antigenica cronica" and by a grant (to P.S.) from the "Fondazione Cassa di Risparmio di Parma e Piacenza." This work was also supported by the Emilia-Romagna Region and Fondi Strutturali Obiettivo 2; Italian Ministry of Health Project "Markers genetici di sindrome coronaria acuta e valutazione della l-arginina nella prevenzione di eventi ischemici" (to D.M. and C.F.); European Union Project "ZINCAGE" 6th Framework Project, Contract FOOD-CT-2003-506850 (to D.M.); and University of Bologna Ricerca Fondamentale Orientata (RFO ex 60%) 2005 and Roberto Pallotti Legacy for Cancer Research Grants (to C.F.).

² Address correspondence and reprint requests to Dr. Paolo Sansoni, Department of Internal Medicine and Biomedical Sciences, University of Parma, via Gramsci 14, 43100 Parma, Italy. E-mail address: paolo.sansoni{at}unipr.it

³ Abbreviation used in this paper: IE-1, immediate early 1 gene product.

Received for publication February 13, 2007. Accepted for publication July 5, 2007.

	References

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 

1. Fagnoni, F. F., R. Vescovini, M. Mazzola, G. Bologna, E. Nigro, G. Lavagetto, C. Franceschi, M. Passeri, P. Sansoni. 1996. Expansion of cytotoxic CD8⁺ CD28^– T cells in healthy ageing people, including centenarians. Immunology 88: 501-507. [Medline]
2. Franceschi, C., S. Valensin, F. F. Fagnoni, C. Barbi, M. Bonafe. 1999. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp. Gerontol. 34: 911-921. [Medline]
3. Fagnoni, F. F., R. Vescovini, G. Passeri, G. Bologna, M. Pedrazzoni, G. Lavagetto, A. Casti, C. Franceschi, M. Passeri, P. Sansoni. 2000. Shortage of circulating naive CD8⁺ T cells provides new insights on immunodeficiency in aging. Blood 95: 2860-2868. [Abstract/Free Full Text]
4. Zanni, F., R. Vescovini, C. Biasini, F. F. Fagnoni, L. Zanlari, A. Telera, P. di Pede, G. Passeri, M. Pedrazzoni, M. Passeri, et al 2003. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8⁺ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp. Gerontol. 38: 981-987. [Medline]
5. Gerli, R., D. Monti, O. Bistoni, A. M. Mazzone, G. Peri, A. Cossarizza, M. Di Gioacchino, M. E. Cesarotti, A. Doni, A. Mantovani, et al 2000. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech. Ageing Dev. 121: 37-46. [Medline]
6. Bruunsgaard, H., K. Andersen-Ranberg, J. B. Hjelmborg, B. K. Pedersen, B. Jeune. 2003. Elevated levels of tumor necrosis factor and mortality in centenarians. Am. J. Med. 115: 278-283. [Medline]
7. Franceschi, C., M. Bonafe, S. Valensin, F. Olivieri, M. De Luca, E. Ottaviani, G. De Benedictis. 2000. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann. NY Acad. Sci. 908: 244-254. [Medline]
8. Sylwester, A. W., B. L. Mitchell, J. B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P. R. Sleath, K. H. Grabstein, N. A. Hosken, F. Kern, et al 2005. Broadly targeted human cytomegalovirus-specific CD4⁺ and CD8⁺ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685. [Abstract/Free Full Text]
9. Pawelec, G., A. Akbar, C. Caruso, R. Solana, B. Grubeck-Loebenstein, A. Wikby. 2005. Human immunosenescence: is it infectious?. Immunol. Rev. 205: 257-268. [Medline]
10. Akbar, A. N., J. M. Fletcher. 2005. Memory T cell homeostasis and senescence during aging. Curr. Opin. Immunol. 17: 480-485. [Medline]
11. Khan, N., N. Shariff, M. Cobbold, R. Bruton, J. A. Ainsworth, A. J. Sinclair, L. Nayak, P. A. Moss. 2002. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169: 1984-1992. [Abstract/Free Full Text]
12. Ouyang, Q., W. M. Wagner, A. Wikby, S. Walter, G. Aubert, A. I. Dodi, P. Travers, G. Pawelec. 2003. Large numbers of dysfunctional CD8⁺ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol. 23: 247-257. [Medline]
13. Vescovini, R., A. Telera, F. F. Fagnoni, C. Biasini, M. C. Medici, P. Valcavi, P. di Pede, G. Lucchini, L. Zanlari, G. Passeri, et al 2004. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8⁺ T cells. Exp. Gerontol. 39: 1233-1243. [Medline]
14. Khan, N., A. Hislop, N. Gudgeon, M. Cobbold, R. Khanna, L. Nayak, A. B. Rickinson, P. A. Moss. 2004. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173: 7481-7489. [Abstract/Free Full Text]
15. Ouyang, Q., W. M. Wagner, W. Zheng, A. Wikby, E. J. Remarque, G. Pawelec. 2004. Dysfunctional CMV-specific CD8⁺ T cells accumulate in the elderly. Exp. Gerontol. 39: 607-613. [Medline]
16. Almanzar, G., S. Schwaiger, B. Jenewein, M. Keller, D. Herndler-Brandstetter, R. Wurzner, D. Schonitzer, B. Grubeck-Loebenstein. 2005. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8⁺ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 79: 3675-3683. [Abstract/Free Full Text]
17. Fletcher, J. M., M. Vukmanovic-Stejic, P. J. Dunne, K. E. Birch, J. E. Cook, S. E. Jackson, M. Salmon, M. H. Rustin, A. N. Akbar. 2005. Cytomegalovirus-specific CD4⁺ T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175: 8218-8225. [Abstract/Free Full Text]
18. Pourgheysari, B., N. Khan, D. Best, R. Bruton, L. Nayak, P. A. H. Moss. 2007. The cytomegalovirus-specific CD4⁺ T cell response expands with age and markedly alters the CD4⁺ T cell repertoire. J. Virol. 81: 7759-7765. [Abstract/Free Full Text]
19. Hoffmeister, B., F. Kiecker, L. Tesfa, H. D. Volk, L. J. Picker, F. Kern. 2003. Mapping T cell epitopes by flow cytometry. Methods 29: 270-281. [Medline]
20. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8⁺ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78. [Medline]
21. Rubio, V., T. B. Stuge, N. Singh, M. R. Betts, J. S. Weber, M. Roederer, P. P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9: 1377-1382. [Medline]
22. Franceschi, C., S. Valensin, M. Bonafe, G. Paolisso, A. I. Yashin, D. Monti, G. De Benedictis. 2000. The network and the remodeling theories of aging: historical background and new perspectives. Exp. Gerontol. 35: 879-896. [Medline]
23. De Martinis, M., C. Franceschi, D. Monti, L. Ginaldi. 2005. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 579: 2035-2039. [Medline]
24. Franceschi, C., M. Capri, D. Monti, S. Giunta, F. Olivieri, F. Sevini, M. P. Panourgia, L. Invidia, L. Celani, M. Scurti, et al 2007. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128: 92-105. [Medline]
25. Schmaltz, H. N., L. P. Fried, Q. L. Xue, J. Walston, S. X. Leng, R. D. Semba. 2005. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J. Am. Geriatr. Soc. 53: 747-754. [Medline]
26. Dunn, H. S., D. J. Haney, S. A. Ghanekar, P. Stepick-Biek, D. B. Lewis, H. T. Maecker. 2002. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J. Infect. Dis. 186: 15-22. [Medline]
27. Kern, F., T. Bunde, N. Faulhaber, F. Kiecker, E. Khatamzas, I. M. Rudawski, A. Pruss, J. W. Gratama, R. Volkmer-Engert, R. Ewert, et al 2002. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185: 1709-1716. [Medline]
28. Sester, M., U. Sester, B. Gartner, B. Kubuschok, M. Girndt, A. Meyerhans, H. Kohler. 2002. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J. Virol. 8: 3748-3755.
29. Weekes, M. P., M. R. Wills, J. G. Sissons, A. J. Carmichael. 2004. Long-term stable expanded human CD4⁺ T cell clones specific for human cytomegalovirus are distributed in both CD45RA^high and CD45RO^high populations. J. Immunol. 173: 5843-5851. [Abstract/Free Full Text]
30. Appay, V., J. J. Zaunders, L. Papagno, J. Sutton, A. Jaramillo, A. Waters, P. Easterbrook, P. Grey, D. Smith, A. J. McMichael, et al 2002. Characterization of CD4⁺ CTLs ex vivo. J. Immunol. 168: 5954-5958. [Abstract/Free Full Text]
31. van Leeuwen, E. M., E. B. Remmerswaal, M. T. Vossen, A. T. Rowshani, P. M. Wertheim-van Dillen, R. A. van Lier, I. J. ten Berge. 2004. Emergence of a CD4⁺CD28^– granzyme B⁺, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173: 1834-1841. [Abstract/Free Full Text]
32. van Leeuwen, E. M., E. B. Remmerswaal, M. H. Heemskerk, I. J. ten Berge, R. A. van Lier. 2006. Strong selection of virus-specific cytotoxic CD4⁺ T-cell clones during primary human cytomegalovirus infection. Blood 108: 3121-3127. [Abstract/Free Full Text]
33. Hegde, N. R., C. Dunn, D. M. Lewinsohn, M. A. Jarvis, J. A. Nelson, D. C. Johnson. 2005. Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4⁺ CTL. J. Exp. Med. 202: 1109-1119. [Abstract/Free Full Text]
34. Adhikary, D., U. Behrends, A. Moosmann, K. Witter, G. W. Bornkamm, J. Mautner. 2006. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J. Exp. Med. 203: 995-1006. [Abstract/Free Full Text]
35. Heller, K. N., C. Gurer, C. Munz. 2006. Virus-specific CD4⁺ T cells: ready for direct attack. J. Exp. Med. 203: 805-808. [Abstract/Free Full Text]
36. Casazza, J. P., M. R. Betts, D. A. Price, M. L. Precopio, L. E. Ruff, J. M. Brenchley, B. J. Hill, M. Roederer, D. C. Douek, R. A. Koup. 2006. Acquisition of direct antiviral effector functions by CMV-specific CD4⁺ T lymphocytes with cellular maturation. J. Exp. Med. 203: 2865-2877. [Abstract/Free Full Text]
37. Kern, F., I. P. Surel, N. Faulhaber, C. Frommel, J. Schneider-Mergener, C. Schonemann, P. Reinke, H. D. Volk. 1999. Target structures of the CD8⁺-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73: 8179-8184. [Abstract/Free Full Text]
38. Kern, F., N. Faulhaber, C. Frommel, E. Khatamzas, S. Prosch, C. Schonemann, I. Kretzschmar, R. Volkmer-Engert, H. D. Volk, P. Reinke. 2000. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30: 1676-1682. [Medline]
39. Khan, N., M. Cobbold, R. Keenan, P. A. Moss. 2001. Comparative analysis of CD8⁺ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J. Infect. Dis. 185: 1025-1034.
40. Bunde, T., A. Kirchner, B. Hoffmeister, D. Habedank, R. Hetzer, G. Cherepnev, S. Proesch, P. Reinke, H. D. Volk, H. Lehmkuhl, F. Kern. 2005. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201: 1031-1036. [Abstract/Free Full Text]
41. Lacey, S. F., J. Martinez, G. Gallez-Hawkins, L. Thao, J. Longmate, W. Haq, R. Spielberger, S. J. Forman, J. A. Zaia, D. J. Diamond. 2005. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8⁺ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients. J. Infect. Dis. 191: 977-984. [Medline]
42. Lacey, S. F., C. La Rosa, W. Zhou, M. C. Sharma, J. Martinez, A. Krishnan, G. Gallez-Hawkins, L. Thao, J. Longmate, R. Spielberger, et al 2006. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J. Infect. Dis. 194: 1410-1421. [Medline]
43. Appay, V., P. R. Dunbar, M. Callan, P. Klenerman, G. M. Gillespie, L. Papagno, G. S. Ogg, A. King, F. Lechner, C. A. Spina, et al 2002. Memory CD8⁺ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385. [Medline]
44. Kalams, S. A., B. D. Walker. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188: 2199-2204. [Free Full Text]
45. Ferguson, F. G., A. Wikby, P. Maxson, J. Olsson, B. Johansson. 1995. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J. Gerontol. A Biol. Sci. Med. Sci. 50: B378-B382. [Abstract]
46. Olsson, J., A. Wikby, B. Johansson, S. Lofgren, B. O. Nilsson, F. G. Ferguson. 2000. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 121: 187-201. [Medline]
47. Wikby, A., B. Johansson, J. Olsson, S. Lofgren, B. O. Nilsson, F. Ferguson. 2002. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 37: 445-453. [Medline]
48. Wikby, A., F. Ferguson, R. Forsey, J. Thompson, J. Strindhall, S. Lofgren, B. O. Nilsson, J. Ernerudh, G. Pawelec, B. Johansson. 2005. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 60: 556-565. [Abstract/Free Full Text]
49. Hadrup, S. R., J. Strindhall, T. Kollgaard, T. Seremet, B. Johansson, G. Pawelec, P. thor Straten, A. Wikby. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176: 2645-2653. [Abstract/Free Full Text]

This article has been cited by other articles:

				A. K. L. Cheung, D. J. Gottlieb, B. Plachter, S. Pepperl-Klindworth, S. Avdic, A. L. Cunningham, A. Abendroth, and B. Slobedman The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency Blood, November 5, 2009; 114(19): 4128 - 4137. [Abstract] [Full Text] [PDF]

				A. N. Hasan, W. J. Kollen, D. Trivedi, A. Selvakumar, B. Dupont, M. Sadelain, and R. J. O'Reilly A Panel of Artificial APCs Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Dominant and Subdominant Viral Epitopes for Adoptive Therapy J. Immunol., August 15, 2009; 183(4): 2837 - 2850. [Abstract] [Full Text] [PDF]

				J. van Bergen, E. M. C. Kooy-Winkelaar, H. van Dongen, F. A. van Gaalen, A. Thompson, T. W. J. Huizinga, M. C. W. Feltkamp, R. E. M. Toes, and F. Koning Functional Killer Ig-Like Receptors on Human Memory CD4+ T Cells Specific for Cytomegalovirus J. Immunol., April 1, 2009; 182(7): 4175 - 4182. [Abstract] [Full Text] [PDF]

				M. C. Verweij, D. Koppers-Lalic, S. Loch, F. Klauschies, H. de la Salle, E. Quinten, P. J. Lehner, A. Mulder, M. R. Knittler, R. Tampe, et al. The Varicellovirus UL49.5 Protein Blocks the Transporter Associated with Antigen Processing (TAP) by Inhibiting Essential Conformational Transitions in the 6+6 Transmembrane TAP Core Complex J. Immunol., October 1, 2008; 181(7): 4894 - 4907. [Abstract] [Full Text] [PDF]

				R. Arens, P. Wang, J. Sidney, A. Loewendorf, A. Sette, S. P. Schoenberger, B. Peters, and C. A. Benedict Cutting Edge: Murine Cytomegalovirus Induces a Polyfunctional CD4 T Cell Response J. Immunol., May 15, 2008; 180(10): 6472 - 6476. [Abstract] [Full Text] [PDF]

				A. Larbi, C. Franceschi, D. Mazzatti, R. Solana, A. Wikby, and G. Pawelec Aging of the Immune System as a Prognostic Factor for Human Longevity Physiology, April 1, 2008; 23(2): 64 - 74. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vescovini, R. Articles by Sansoni, P. Search for Related Content PubMed PubMed Citation Articles by Vescovini, R. Articles by Sansoni, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH